Isatin derivatives as broad-spectrum antiviral agents: the current landscape

Med Chem Res. 2022;31(2):244-273. doi: 10.1007/s00044-021-02832-4. Epub 2022 Jan 13.

Abstract

In recent decades, several viruses have resulted in large outbreaks with serious health, economic and social consequences. The current unprecedented outbreak of the new coronavirus, SARS-COV-2, necessitates intensive efforts for delivering effective therapies to eradicate such a deadly virus. Isatin is an opulent heterocycle that has been proven to provide tremendous opportunities in the area of drug discovery. Over the last fifty years, suitably functionalized isatin has shown remarkable and broad-spectrum antiviral properties. The review herein is an attempt to compile all of the reported information about the antiviral activity of isatin derivatives with an emphasis on their structure-activity relationships (SARs) along with mechanistic and molecular modeling studies. In this regard, we are confident that the review will afford the scientific community a valuable platform to generate more potent and cost-effective antiviral therapies based on isatin templates.

Keywords: Antiviral drugs; Indoline-2,3-dione; Isatin; SARS-COV-2; Structure-activity relationships (SARs); Viruses.

Publication types

  • Review